Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-09-21
2011-11-29
Lu, Frank W (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C536S023100, C536S024300, C536S024330
Reexamination Certificate
active
08067160
ABSTRACT:
The invention includes method of determining if a subject has a genetic predisposition to clinically diagnosed schizophrenia (SZ), schizotypal personality disorder (SPD), and/or schizoaffective disorder (SD).
REFERENCES:
patent: 2006/0177851 (2006-08-01), Brennan et al.
Pearson et al., How to Interpret a Genome-wide Association Study. JAMA, 299, 1335-1344, 2008.
Stefansson et al., Common variants conferring risk of schizophrenia. Nature, 460, 744-747, 2009.
Shi et al., Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature, 460, 753-757, 2009.
Hennah et al., “Hapltype analysis and identification of genes for complex trait: examples from schizophrenia,”Annals of Medicine, 36:322-331 (2004).
Riley et al., “Molecular genetics studies of schizophrenia,”European Journal of Human Genetics, 14:669-680 (2006).
Hegele, R.A., “SNP judgment and freedom of association,”Arteriocler. Thromb. Vasc. Biol., 22:1058-1061 (2002).
Baker et al., “COMT Va1108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome,”Biol. Psychiatry, 58(1):23-31 (2005).
Brennan et al., “Polymorphic markers for the arylsulfatase A gene reveal a greatly expanded meiotic map for the human 22q telomeric region ,”Genomics, 63:430-432 (2000).
Cadenhead, K.S., “Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome,”Psychiatric Clinics of North America, 25(4):837-853 (2002).
Callicott et al., “Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia,”Proc. Natl. Acad. Sci USA, 102(24):8627-8632 (2005).
Cannon et al., “Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory,”Arch. Gen. Psychiatry, 62(11):1205-1213 (2005).
Durand et al., “Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders,”Nat. Genet., 39(1):25-27 (2007) [Epub Dec. 17, 2006].
Gornick et al., “Dysbindin (DTNBP1, 6p22.3) is Associated with Childhood-Onset Psychosis and Endophenotypes Measured by the Premorbid Adjustment Scale (PAS),”J. Autism Dev. Disord., 35(6):831-838 (2005).
Gothelf et al., “COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome,”Nat. Neurosci., 8(11):1500-1502 (2005).
Gottesman and Gould, “The endophenotype concept in psychiatry: etymology and strategic intentions,”Am. J. Psychiatry, 160(4):636-645 (2003).
Hallmayer et al., “Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit,”Am. J. Hum. Genet., 77(3):468-476 (2005).
Harrison and Owen, “Genes for schizophrenia? Recent findings and their pathophysiological implications,”Lancet, 361(9355):417-419 (2003).
Heinrichs, R.W., “Meta-analysis and the science of schizophrenia: variant evidence or evidence of variants?”Neuroscience&Biobehavioral Reviews, 28(4):379-394 (2004).
Kaufmann et al., “NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees,”Am. J. Med. Genet., 81:282-289 (1998).
Kavenoff et al., “One the nature of chromosome-sized DNA molecules,”Cold Spring Harbor Symposia on Quantitative Biology, 38:1-8 (1974).
Kendler et al., “Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study,”Am. J. Psychiatry, 152(5):749-754 (1995).
Mattila et al., “Fidelity of DNA synthesis by theThermococcus litoralisDNA polymerase—an extremely heat stable enzyme with proofreading activity,”Nucleic Acids Res., 19:4967-4973 (1991).
Saiki et al., “Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes,”Nature, 324:163-166 (1986).
Sheffield et al., “Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes,”Proc. Natl. Acad. Sci. USA, 86:232-236 (1989).
Brennan Mark David
Phillips D. Kay
Fish & Richardson P.C.
Lu Frank W
University of Louisville Research Foundation Inc.
LandOfFree
Genetic markers of schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic markers of schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic markers of schizophrenia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4312244